| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From Internal Medicine* and the Department of Anatomy,** St. Marianna University School of Medicine, Kawasaki; Center for Tsukuba Advanced Research Alliance, University of Tsukuba, Ibaragi; Eiken Chemical Company Limited, Tochigi; Tanabe Seiyaku Company Limited, Osaka; Genome Information Research Center,¶ Osaka University, Osaka; Internal Medicine,|| University of Tokyo, Tokyo; and the Department of Biochemistry, Niigata University School of Medicine, Niigata, Japan
Urinary excretion of human liver-type fatty acid-binding protein (hL-FABP), which is expressed in human proximal tubules and engaged in free fatty acid (FFA) metabolism, was reported to reflect the clinical prognosis of chronic kidney disease. Here we have investigated the pathophysiological significance of hL-FABP in a model of protein overload nephropathy. Because L-FABP is not expressed in the wild-type mice, we generated hL-FABP chromosomal gene transgenic (Tg) mice. Tg mice were intraperitoneally injected with bovine serum albumin (BSA) replete with FFAs (r-BSA group) or FFA-depleted BSA (d-BSA group). The r-BSA group developed significantly more severe tubulointerstitial damage than did the d-BSA group. Renal expression of the hL-FABP gene was more up-regulated, and urinary excretion of hL-FABP was significantly higher, in the r-BSA group than in the d-BSA group. Furthermore, compared with their wild-type littermates injected with r-BSA, the number of infiltrated macrophages was significantly attenuated in Tg mice injected with it on day 28. In patients with kidney disease (n = 50), urinary hL-FABP was correlated with both urinary protein and the severity of tubulointerstitial injury. In conclusion, our experimental model suggests that urinary excretion of hL-FABP reflects stresses, such as urinary protein overload, on the proximal tubules. The clinical observations support this hypothesis.
This article has been cited by other articles:
 |
|
 |
|
  K. J. Kelly, P. Wu, C. E. Patterson, C. Temm, and J. H. Dominguez LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1136 - F1145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M Hofstra, J. K. Deegens, E. J Steenbergen, and J. F. Wetzels Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy Nephrol. Dial. Transplant., April 10, 2008; (2008) gfn190v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bolignano, G. Coppolino, S. Campo, C. Aloisi, G. Nicocia, N. Frisina, and M. Buemi Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients Nephrol. Dial. Transplant., January 1, 2008; 23(1): 414 - 416. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cabre, I. Lazaro, J. Girona, J. M. Manzanares, F. Marimon, N. Plana, M. Heras, and L. Masana Plasma Fatty Acid-Binding Protein 4 Increases with Renal Dysfunction in Type 2 Diabetic Patients without Microalbuminuria Clin. Chem., January 1, 2008; 54(1): 181 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kamijo, K. Hora, K. Kono, K. Takahashi, M. Higuchi, T. Ehara, K. Kiyosawa, H. Shigematsu, F. J. Gonzalez, and T. Aoyama PPAR{alpha} Protects Proximal Tubular Cells from Acute Fatty Acid Toxicity J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3089 - 3100. [Full Text] [PDF]
|
|
|
|
|
|
T. Yamamoto, E. Noiri, Y. Ono, K. Doi, K. Negishi, A. Kamijo, K. Kimura, T. Fujita, T. Kinukawa, H. Taniguchi, et al. Renal L-Type Fatty Acid Binding Protein in Acute Ischemic Injury J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2894 - 2902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Feldkamp, A. Kribben, N. F. Roeser, T. Ostrowski, and J. M. Weinberg Alleviation of fatty acid and hypoxia-reoxygenation-induced proximal tubule deenergization by ADP/ATP carrier inhibition and glutamate Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1606 - F1616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kamijo-Ikemori, T. Sugaya, A. Obama, J. Hiroi, H. Miura, M. Watanabe, T. Kumai, R. Ohtani-Kaneko, K. Hirata, and K. Kimura Liver-Type Fatty Acid-Binding Protein Attenuates Renal Injury Induced by Unilateral Ureteral Obstruction Am. J. Pathol., October 1, 2006; 169(4): 1107 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Suzuki, T. Babazono, H. Murata, and Y. Iwamoto Clinical Significance of Urinary Liver-Type Fatty Acid-Binding Protein in Patients With Diabetic Nephropathy Diabetes Care, August 1, 2005; 28(8): 2038 - 2039. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
